-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28

Benzinga·08/11/2026 15:42:53
Listen to the news
Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and raises the price target from $21 to $28.